BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22323468)

  • 1. The diurnal variation of matrix metalloproteinase-9 and its associated factors in human tears.
    Markoulli M; Papas E; Cole N; Holden BA
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1479-84. PubMed ID: 22323468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of contact lens wear on the diurnal profile of matrix metalloproteinase 9 in tears.
    Markoulli M; Papas E; Cole N; Holden B
    Optom Vis Sci; 2013 May; 90(5):419-29. PubMed ID: 23563442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
    Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do salivary and serum collagenases have a role in an association between obstructive sleep apnea syndrome and periodontal disease? A preliminary case-control study.
    Nizam N; Basoglu OK; Tasbakan MS; Holthöfer A; Tervahartiala T; Sorsa T; Buduneli N
    Arch Oral Biol; 2015 Jan; 60(1):134-43. PubMed ID: 25455127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
    Wang M; Zhang Q; Zhao X; Dong G; Li C
    Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
    Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM
    Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
    Tsai HT; Su PH; Lee TH; Tee YT; Lin LY; Yang SF; Wang PH
    Clin Chim Acta; 2011 Jun; 412(13-14):1252-6. PubMed ID: 21439274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of matrix metalloproteinases and neutrophil gelatinase-associated lipocalin in central and peripheral arterial aneurysms.
    Serra R; Grande R; Montemurro R; Butrico L; Caliò FG; Mastrangelo D; Scarcello E; Gallelli L; Buffone G; de Franciscis S
    Surgery; 2015 Jan; 157(1):155-62. PubMed ID: 25444221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis.
    Musiał K; Zwolińska D
    Cell Stress Chaperones; 2011 Mar; 16(2):163-71. PubMed ID: 20853162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
    Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
    Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
    Kiczak L; Tomaszek A; Bania J; Paslawska U; Zacharski M; Janiszewski A; Rybinska I; Dziegiel P; von Haehling S; Ardehali H; Jankowska EA; Ponikowski P
    J Physiol Pharmacol; 2014 Jun; 65(3):365-75. PubMed ID: 24930508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
    Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
    Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Margeli A; Papassotiriou I
    Eur J Endocrinol; 2008 Apr; 158(4):525-31. PubMed ID: 18362300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhoids and matrix metalloproteinases: A multicenter study on the predictive role of biomarkers.
    Serra R; Gallelli L; Grande R; Amato B; De Caridi G; Sammarco G; Ferrari F; Butrico L; Gallo G; Rizzuto A; de Franciscis S; Sacco R
    Surgery; 2016 Feb; 159(2):487-94. PubMed ID: 26263832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
    Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
    Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.
    Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX
    Dis Markers; 2015; 2015():138974. PubMed ID: 26663949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children.
    Korzeniecka-Kozerska A; Wasilewska A; Tenderenda E; Sulik A; Cybulski K
    Dis Markers; 2013; 34(5):357-62. PubMed ID: 23478276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
    Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW
    Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
    Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
    Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
    Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
    BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.